Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Duke University GlaxoSmithKline |
---|---|
Information provided by: | Duke University |
ClinicalTrials.gov Identifier: | NCT00136383 |
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Condition | Intervention | Phase |
---|---|---|
Depressive Symptoms |
Drug: paroxetine versus duloxetine |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Study of the Effects of Paroxetine vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control |
Estimated Enrollment: | 40 |
Study Start Date: | March 2005 |
Study Completion Date: | June 2007 |
This double-blind placebo-controlled study will test the hypothesis that greater reduction in heart rate variability will be associated with duloxetine than paroxetine in outpatients with major depressive disorder. We will also examine the relationship between changes in heart rate variability to the magnitude of serotonin and norepinephrine transporter occupancy produced by each drug.
Ages Eligible for Study: | 20 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, North Carolina | |
Duke University Medical Center | |
Durham, North Carolina, United States, 27705 |
Principal Investigator: | Wei Zhang, M.D., Ph.D. | Duke University |
Study ID Numbers: | 6956-05-3R0 |
Study First Received: | August 25, 2005 |
Last Updated: | September 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00136383 |
Health Authority: | United States: Food and Drug Administration |
Dopamine Depression Depressive Disorder Paroxetine |
Serotonin Duloxetine Behavioral Symptoms |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Serotonin Uptake Inhibitors Pharmacologic Actions Serotonin Agents Therapeutic Uses Dopamine Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |